Comparison of the Efficacy and Safety of 160 mcg Ciclesonide Administered Once Daily in the Evening with ot without Different Spacer Types in Patients with Asthma
- Conditions
- Asthma bronchialMedDRA version: 6.1Level: PTClassification code 10003553
- Registration Number
- EUCTR2005-002163-84-IT
- Lead Sponsor
- ALTANA PHARMA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method